These results underscore the significant impact of IGF-1 on iNOS activity in obese rat hearts.<h4>Discussion</h4>Our findings suggest that the treatment of obese rats with IGF-1 could have significant implications for cardiac function, particularly in the context of obesity, by regulating cardiac iNOS. Here, NOS2 is linked to obesity disorder.